Assignee
BEIJING MABWORKS BIOTECH CO LTD
CN·19 granted patents·5 pending applications·69 citations·filing 2017–2024
Top patents by PatentIndex Score
24 records- 0195US10421817B1Antibodies binding human Claudin 18.2 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Sep 24, 2019·33 cites·19 claims
- 0294US10570210B1Antibodies binding CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Feb 25, 2020·13 cites·19 claims
- 0392US10946092B1Antibodies binding LAG3 and methods of treatment using themBEIJING MABWORKS BIOTECH CO LTD·Filed 2020·Granted Mar 16, 2021·3 cites·20 claims
- 0488US10577424B1Antibodies binding VISTA and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Mar 3, 2020·5 cites·19 claims
- 0588US10442866B1Antibodies binding OX40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Oct 15, 2019·8 cites·19 claims
- 0682US10662249B1Antibodies targeting CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 26, 2020·1 cites·17 claims
- 0782US10377833B2Bispecific anti-HER2 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2017·Granted Aug 13, 2019·3 cites·1 claims
- 0877US10654937B1CD40 specific antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 0977US10654939B1Antibodies specific to CD40 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 1077US10647776B1Anti-CD40 antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 12, 2020·0 cites·17 claims
- 1177US9745382B1Bispecific anti-HER2 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2017·Granted Aug 29, 2017·3 cites·20 claims
- 1273US12084520B2Antibodies binding BCMA and CD3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Granted Sep 10, 2024·0 cites·20 claims
- 1373US10654938B1CD40 binding antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted May 19, 2020·0 cites·17 claims
- 1471US2024392042A1Antibodies binding cd3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 1569US11970541B2Anti-CD20 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Granted Apr 30, 2024·0 cites·3 claims
- 1666US11091558B2Anti-OX40 antibodies and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Aug 17, 2021·0 cites·12 claims
- 1764US12590155B2Molecules binding PD-L1 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Granted Mar 31, 2026·0 cites·17 claims
- 1862US2023348629A1Bispecific molecules binding tigit and vegf and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1958US2023348612A1Single-chain fragment variable comprising mutant light chain framework regionBEIJING MABWORKS BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 2057US11718674B2Antibodies binding PD-L1 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Granted Aug 8, 2023·0 cites·15 claims
- 2156US11208492B2Anti-CD20 antibodyBEIJING MABWORKS BIOTECH CO LTD·Filed 2019·Granted Dec 28, 2021·0 cites·2 claims
- 2256US2026078195A1Multi-specific antibody binding to bcma, gprc5d and cd3, and use thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2353US2022396617A1Antibodies binding tigit and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2452US12180280B2Antibodies binding human and monkey CD3 and uses thereofBEIJING MABWORKS BIOTECH CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when BEIJING MABWORKS BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →